Virpax Pharmaceuticals Inc [NASDAQ: VRPX] traded at a high on Friday, posting a 32.81 gain after which it closed the day’ session at $1.70.
The results of the trading session contributed to over 48148314 shares changing hands. Over the past one week, the price volatility of Virpax Pharmaceuticals Inc stands at 39.84% while the volatility over the past one month is 31.00%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for VRPX stock reached $8.18 million, with 4.81 million shares outstanding and 4.28 million shares in the current float. Compared to the average trading volume of 5.14M shares, VRPX reached a trading volume of 48148314 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Virpax Pharmaceuticals Inc [VRPX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VRPX shares is $3.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VRPX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
How has VRPX stock performed recently?
Virpax Pharmaceuticals Inc [VRPX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 25.00. With this latest performance, VRPX shares gained by 198.19% in over the last four-week period, additionally sinking by -43.07% over the last 6 months – not to mention a drop of -81.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VRPX stock in for the last two-week period is set at 63.30, with the RSI for the last a single of trading hit 66.22, and the three-weeks RSI is set at 58.70 for Virpax Pharmaceuticals Inc [VRPX]. The present Moving Average for the last 50 days of trading for this stock 0.9981, while it was recorded at 1.4020 for the last single week of trading, and 3.6144 for the last 200 days.
Virpax Pharmaceuticals Inc [VRPX]: Deeper insight into the fundamentals
Virpax Pharmaceuticals Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.72 and a Current Ratio set at 0.72.
Insider trade positions for Virpax Pharmaceuticals Inc [VRPX]
The top three institutional holders of VRPX stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in VRPX stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in VRPX stock with ownership which is approximately 5.1238%.
